Karteikarten
oncology WIP
Karten in diesem Stapel (12)
- 1cancer screening programs in australiabreast cancer screen (mammogram)
bowel cancer screen (5 yearly from 50, will become 2 yearly)
pap smear - 2purpose of surgery in cancersurgical removal of tumour best hope a cure
reduces risk of metastases
metastatic lesions are more difficult to remove, so may not be useful in that situation
may follow chemo/radio (may be shrunk down to be operable) - 3radiotherapyphysical form of therapy that destroys tissue in its path
can be mono/combo therapy
localised tumour control at primary site of disease
used in breast, hodgkins, prostate, head/neck cancers
modality for symptom control in lesions
localised side effects (skin burning, N&V) - 4chemosolid tumours may be cured with chemo, leukaemia, some lymphomas can be treated with chemo
can be an adjunct to surgery of localised cancer - 5role of adjuvant therapyadjuvant chemo given to help reduce risk of metastatic lesions which are too hard to see until it's too late and their size makes them incurable
can also be used prior to surgery to shrink tumours down to operable sizes
neo adjuvant therapy includes radiotherapy - 6haematological toxicityanaemia, neutropenia, thrombocytopenia
- 7mucositisinflammation, and ulceration of mucus membrane anywhere in the GIT
infections - viral, bacterial, fungal - 8neutropeniadose limiting toxicity, may delay subsequent treatment
treatment: granulocyte colony stimulating factor (G-CSF) to reduce depth and duration of neutropenia
infections: treat with IV antibiotics (broad spectrum)
ceftaxidime, tazo/pip, cefepine
+ amino glycoside
+ vancomycin (if skin infection) - 9N&Vchemo probably releases emetic neurotransmitters that bind to receptors in the gut and CNS
significant impact on QOL
treat with antiemetics 1-2 hrs prior to chemo and for up to 5 days after
dopamine antagonists (metoclopramide, domperidone, prochlorperazine), bentos, olanzapine - 10breast cancerleading cancer dx in women
2nd leading cause of death
early stage disease often curable - 11risk factorsBRCA1 +BRCA2
HER-2 biomarker - 12adjuvant therapymenopausal status
ER/PR
HER2 status
Informationen
- Beschreibung
- therapeutics (cancer) Karteikarten am oncology WIP, erstellt von Amelia Claire am 16/10/2018.
- Erstellt von
- Amelia Claire · Okt 2018
- Aktualisiert
- 16 Okt 2018
- Aufrufe
- 7
- Bewertung